We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.05B
AUM Growth
+$28.3M
Cap. Flow
+$164M
Cap. Flow %
3.25%
Top 10 Hldgs %
19.52%
Holding
541
New
26
Increased
159
Reduced
108
Closed
21

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$19.4M
2
BBWI icon
Bath & Body Works
BBWI
+$18.4M
3
AME icon
Ametek
AME
+$14.3M
4
NEE icon
NextEra Energy
NEE
+$13M
5
FL
Foot Locker
FL
+$12.7M

Sector Composition

Rank Sector Weight
1 Technology 29.95%
2 Healthcare 19.46%
3 Consumer Discretionary 13.98%
4 Financials 9.64%
5 Industrials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WU icon
326
Western Union
WU
$2.28B
$1.07M 0.02%
51,400
IDXX icon
327
Idexx Laboratories
IDXX
$46.3B
$1.06M 0.02%
1,695
+795
+88% +$534K
WFC icon
328
Wells Fargo
WFC
$269B
$1.06M 0.02%
22,581
+1,253
+6% +$58K
ALLO icon
329
Allogene Therapeutics
ALLO
$656M
$1.05M 0.02%
40,800
FATE icon
330
Fate Therapeutics
FATE
$303M
$1.03M 0.02%
17,200
AMRN
331
Amarin Corp
AMRN
$300M
$1.02M 0.02%
9,900
GPRK icon
332
GeoPark
GPRK
$608M
$988K 0.02%
80,000
GS icon
333
Goldman Sachs
GS
$311B
$977K 0.02%
2,539
+141
+6% +$55.1K
OCUL icon
334
Ocular Therapeutix
OCUL
$1.9B
$971K 0.02%
95,800
+26,000
+37% +$292K
B
335
Barrick Mining
B
$64.3B
$967K 0.02%
53,600
-830
-2% -$16.7K
LNG icon
336
Cheniere Energy
LNG
$54.2B
$908K 0.02%
9,300
AME icon
337
Ametek
AME
$58.5B
$893K 0.02%
7,052
-106,439
-94% -$14.3M
CNQ icon
338
Canadian Natural Resources
CNQ
$96.5B
$877K 0.02%
49,008
+38,798
+380% +$639K
KMI icon
339
Kinder Morgan
KMI
$69.9B
$860K 0.02%
50,800
TVTX icon
340
Travere Therapeutics
TVTX
$5.24B
$854K 0.02%
35,600
HIG icon
341
Hartford Financial Services
HIG
$39B
$846K 0.02%
11,800
ADI icon
342
Analog Devices
ADI
$185B
$844K 0.02%
5,000
KRTX
343
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$840K 0.02%
7,070
NKTR icon
344
Nektar Therapeutics
NKTR
$2.44B
$839K 0.02%
3,120
FCX icon
345
Freeport-McMoran
FCX
$96.7B
$838K 0.02%
25,400
ACGL icon
346
Arch Capital
ACGL
$34.1B
$835K 0.02%
21,500
PCRX icon
347
Pacira BioSciences
PCRX
$1.07B
$817K 0.02%
14,400
EDIT icon
348
Editas Medicine
EDIT
$422M
$808K 0.02%
19,000
GE icon
349
GE Aerospace
GE
$392B
$780K 0.02%
11,781
+641
+6% +$41.2K
BILI icon
350
Bilibili
BILI
$7.96B
$773K 0.02%
12,000

Similar funds

Erste Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Erste Asset Management held 541 positions worth $5.05B, up 0.56% from $5.02B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Erste Asset Management deployed $164M of net new capital in Q3 2021, opening 26 new positions and adding to 159 existing holdings. Its largest new stake was Victoria's Secret: 600,333 shares worth $33.2M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Oracle, an estimated $19.4M trimmed.

  • Erste Asset Management's largest Q3 2021 buy was Victoria's Secret: 600,333 shares worth $33.2M.
  • Erste Asset Management added most to Automatic Data Processing in Q3 2021, an estimated $20M increase.
  • Erste Asset Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $19.4M.
  • Erste Asset Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.77M.
  • Erste Asset Management's ten largest holdings make up 20% of its $5.05B portfolio in Q3 2021.
  • Erste Asset Management opened 26 new positions and closed 21 in Q3 2021.
  • Erste Asset Management's portfolio value rose 0.56% quarter-over-quarter to $5.05B.

Based on Erste Asset Management's 13F filing for Q3 2021, filed 25 Nov 2024.